Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 11160616
System and method of performing treatment along a lumen network
granted -
US 11162098
Complement component C5 iRNA compositions and methods of use thereof
granted -
US 11160800
Methods of treatment using a JAK inhibitor compound
granted -
US 11160826
Cholesterol lowering drugs for the treatment of hepatic encephalopathy
granted -
US 11160850
Compositions of human prothrombin and activated factor X for improving hemostasis in the treatment of bleeding disorders
granted -
US 11161826
Manufacturing methods and polymorphs of a thiazoline anti-hyperalgesic agent
granted -
US 11161876
Anti-inflammatory nanofibers
granted -
US 11161908
BAFF-R targeted chimeric antigen receptor-modified t-cells and uses thereof
granted -
US 11162075
Methods and compositions for inducing hematopoietic cell differentiation
granted -
US 11162945
Methods and compositions for detecting single T cell receptor affinity and sequence
granted -
US 11160810
Fused imidazo-piperidine JAK inhibitor compound
granted -
US 11160833
Bispecific OR-gate chimeric antigen receptor responsive to CD19 and CD20
granted -
US 11162096
Methods for modulating expression of C9ORF72 antisense transcript
granted -
US 11162076
Methods and compositions for inducing hematopoietic cell differentiation
granted -
US 11162079
Blood type O Rh-hypo-immunogenic pluripotent cells
granted -
US 11162063
Methods and apparatus for conditioning cell populations for cell therapies
granted -
US 11161906
Multispecific antibodies, multispecific activatable antibodies and methods of using the same
granted -
US 11161875
Inhibition of pulmonary fibrosis with nutlin-3a and peptides
granted -
US 11161864
Sting agonists
granted -
US 11161873
Chemoselective thiol-conjugation with alkene or alkyne-phosphonamidates
granted -
US 11160779
Methods of providing solriamfetol therapy to subjects with impaired renal function
granted -
US 11161828
Class of bisquaternary ammonium compound as well as the preparative method and the use thereof
granted -
US 11160872
Pyrrolobenzodiazepine-antibody conjugates
granted -
US 11160859
Materials and methods for respiratory disease control in canines
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.